A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The primary objective is to compare the efficacy between three doses of AZD0865 (25, 50 and 75 mg). The secondary objectives are to compare the efficacy between the three doses of AZD0865 and esomeprazole 20 mg and to evaluate the safety and tolerability of AZD0865.
Epistemonikos ID: 7321f6d09cf2189d4e060d5ddcbd66b428d800ba
First added on: May 04, 2024